[AKEI NEWSLETTER 22호]"2021 Bio-pharmaceutical Industry Exhibition Conpex."
Page Info
내용
"2021
Bio-pharmaceutical Industry Exhibition Conpex."
Incheon
City (mayor Park Nam-chun) held the 2021 Bio-Pharmaceutical Incheon Global
Conpex event at Songdo Convensia for three days from November 22 to 24.
This
year, various events such as conferences, exhibitions, and global export
consultations were held at the same time to enhance synergy between related
fields related to the bio-pharmaceutical industry. Institutions specializing in
related fields such as KOTRA, Incheon Tourism Organization, Korea
Pharmaceutical Export-Import Association, and K-Fairs participated together.
The
conference, which marks its sixth anniversary, was divided into sessions in Sri
Lanka, the Philippines, and South Korea under the theme of "Entering the
Overseas Market of Bio and Drugs."
Celltrion's
senior vice president Lee Sang-joon announced a successful case of Celltrion's
pioneering of a new industry called "antibody biosimilar" for the
first time in the world, pioneering a path that others have not taken.
About
80 bio-pharmaceutical companies, including "Samsung Biologics,"
participated in bio-analysis and diagnosis, exhibitions of their products and
services such as raw materials and finished drugs, and corporate investment
counseling.
In
connection with the simultaneous bio-original material localization promotion
meeting, the company introduced products and technologies of the project and
its suppliers through the operation of the "Bio-original material
localization supply chain" in Incheon.
50
pharmaceutical and bio companies nationwide and more than 100 buyers from 30
overseas countries (CIS, Middle East, Latin America, etc.) participated in the
export consultation meeting aimed at expanding K-Bio exports.
This
export consultation meeting is expected to contribute to the vitalization of
the Incheon bio-industry in that it serves as an industrial platform for
domestic companies and overseas buyers.